Global Gadolinium-based Contrast Media Market Research Report 2021

Global Gadolinium-based Contrast Media Market Research Report 2021

Report Code: KNJ787559 | No. of Pages: 120 | Category: Medical Devices
Publisher: QYResearch | Date of Publish: Jun-2021
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Extracellular Agents
    Blood Pool Agents
    Hepatobiliary Agents

Segment by Application
    Cardiovascular
    Neurology
    Cancer
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E

By Company
    Bayer AG
    GE Healthcare(GE)
    Guerbet
    Lantheus Medical Imaging
    Bracco Diagnostics Inc.
    Trivitron Healthcare
    Nano Therapeutics Pvt. Ltd.
    Nanoscan Imaging LLC
    Jodas Expoim Pvt Ltd
    Magnus Health(Veracross LLC)
    Spago Nanomedical
1 Gadolinium-based Contrast Media Market Overview
    1.1 Product Overview and Scope of Gadolinium-based Contrast Media
    1.2 Gadolinium-based Contrast Media Segment by Type
        1.2.1 Global Gadolinium-based Contrast Media Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Extracellular Agents
        1.2.3 Blood Pool Agents
        1.2.4 Hepatobiliary Agents
    1.3 Gadolinium-based Contrast Media Segment by Application
        1.3.1 Gadolinium-based Contrast Media Sales Comparison by Application: (2021-2027)
        1.3.2 Cardiovascular
        1.3.3 Neurology
        1.3.4 Cancer
        1.3.5 Others
    1.4 Global Gadolinium-based Contrast Media Market Size Estimates and Forecasts
        1.4.1 Global Gadolinium-based Contrast Media Revenue 2016-2027
        1.4.2 Global Gadolinium-based Contrast Media Sales 2016-2027
        1.4.3 Gadolinium-based Contrast Media Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gadolinium-based Contrast Media Market Competition by Manufacturers
    2.1 Global Gadolinium-based Contrast Media Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Gadolinium-based Contrast Media Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Gadolinium-based Contrast Media Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Gadolinium-based Contrast Media Manufacturing Sites, Area Served, Product Type
    2.5 Gadolinium-based Contrast Media Market Competitive Situation and Trends
        2.5.1 Gadolinium-based Contrast Media Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Gadolinium-based Contrast Media Players Market Share by Revenue
        2.5.3 Global Gadolinium-based Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gadolinium-based Contrast Media Retrospective Market Scenario by Region
    3.1 Global Gadolinium-based Contrast Media Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Gadolinium-based Contrast Media Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Gadolinium-based Contrast Media Market Facts & Figures by Country
        3.3.1 North America Gadolinium-based Contrast Media Sales by Country
        3.3.2 North America Gadolinium-based Contrast Media Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Gadolinium-based Contrast Media Market Facts & Figures by Country
        3.4.1 Europe Gadolinium-based Contrast Media Sales by Country
        3.4.2 Europe Gadolinium-based Contrast Media Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Gadolinium-based Contrast Media Market Facts & Figures by Region
        3.5.1 Asia Pacific Gadolinium-based Contrast Media Sales by Region
        3.5.2 Asia Pacific Gadolinium-based Contrast Media Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Gadolinium-based Contrast Media Market Facts & Figures by Country
        3.6.1 Latin America Gadolinium-based Contrast Media Sales by Country
        3.6.2 Latin America Gadolinium-based Contrast Media Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Gadolinium-based Contrast Media Market Facts & Figures by Country
        3.7.1 Middle East and Africa Gadolinium-based Contrast Media Sales by Country
        3.7.2 Middle East and Africa Gadolinium-based Contrast Media Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Gadolinium-based Contrast Media Historic Market Analysis by Type
    4.1 Global Gadolinium-based Contrast Media Sales Market Share by Type (2016-2021)
    4.2 Global Gadolinium-based Contrast Media Revenue Market Share by Type (2016-2021)
    4.3 Global Gadolinium-based Contrast Media Price by Type (2016-2021)

5 Global Gadolinium-based Contrast Media Historic Market Analysis by Application
    5.1 Global Gadolinium-based Contrast Media Sales Market Share by Application (2016-2021)
    5.2 Global Gadolinium-based Contrast Media Revenue Market Share by Application (2016-2021)
    5.3 Global Gadolinium-based Contrast Media Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Bayer AG
        6.1.1 Bayer AG Corporation Information
        6.1.2 Bayer AG Description and Business Overview
        6.1.3 Bayer AG Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Bayer AG Product Portfolio
        6.1.5 Bayer AG Recent Developments/Updates
    6.2 GE Healthcare(GE)
        6.2.1 GE Healthcare(GE) Corporation Information
        6.2.2 GE Healthcare(GE) Description and Business Overview
        6.2.3 GE Healthcare(GE) Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 GE Healthcare(GE) Product Portfolio
        6.2.5 GE Healthcare(GE) Recent Developments/Updates
    6.3 Guerbet
        6.3.1 Guerbet Corporation Information
        6.3.2 Guerbet Description and Business Overview
        6.3.3 Guerbet Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Guerbet Product Portfolio
        6.3.5 Guerbet Recent Developments/Updates
    6.4 Lantheus Medical Imaging
        6.4.1 Lantheus Medical Imaging Corporation Information
        6.4.2 Lantheus Medical Imaging Description and Business Overview
        6.4.3 Lantheus Medical Imaging Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Lantheus Medical Imaging Product Portfolio
        6.4.5 Lantheus Medical Imaging Recent Developments/Updates
    6.5 Bracco Diagnostics Inc.
        6.5.1 Bracco Diagnostics Inc. Corporation Information
        6.5.2 Bracco Diagnostics Inc. Description and Business Overview
        6.5.3 Bracco Diagnostics Inc. Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Bracco Diagnostics Inc. Product Portfolio
        6.5.5 Bracco Diagnostics Inc. Recent Developments/Updates
    6.6 Trivitron Healthcare
        6.6.1 Trivitron Healthcare Corporation Information
        6.6.2 Trivitron Healthcare Description and Business Overview
        6.6.3 Trivitron Healthcare Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Trivitron Healthcare Product Portfolio
        6.6.5 Trivitron Healthcare Recent Developments/Updates
    6.7 Nano Therapeutics Pvt. Ltd.
        6.6.1 Nano Therapeutics Pvt. Ltd. Corporation Information
        6.6.2 Nano Therapeutics Pvt. Ltd. Description and Business Overview
        6.6.3 Nano Therapeutics Pvt. Ltd. Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Nano Therapeutics Pvt. Ltd. Product Portfolio
        6.7.5 Nano Therapeutics Pvt. Ltd. Recent Developments/Updates
    6.8 Nanoscan Imaging LLC
        6.8.1 Nanoscan Imaging LLC Corporation Information
        6.8.2 Nanoscan Imaging LLC Description and Business Overview
        6.8.3 Nanoscan Imaging LLC Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Nanoscan Imaging LLC Product Portfolio
        6.8.5 Nanoscan Imaging LLC Recent Developments/Updates
    6.9 Jodas Expoim Pvt Ltd
        6.9.1 Jodas Expoim Pvt Ltd Corporation Information
        6.9.2 Jodas Expoim Pvt Ltd Description and Business Overview
        6.9.3 Jodas Expoim Pvt Ltd Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Jodas Expoim Pvt Ltd Product Portfolio
        6.9.5 Jodas Expoim Pvt Ltd Recent Developments/Updates
    6.10 Magnus Health(Veracross LLC)
        6.10.1 Magnus Health(Veracross LLC) Corporation Information
        6.10.2 Magnus Health(Veracross LLC) Description and Business Overview
        6.10.3 Magnus Health(Veracross LLC) Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Magnus Health(Veracross LLC) Product Portfolio
        6.10.5 Magnus Health(Veracross LLC) Recent Developments/Updates
    6.11 Spago Nanomedical
        6.11.1 Spago Nanomedical Corporation Information
        6.11.2 Spago Nanomedical Gadolinium-based Contrast Media Description and Business Overview
        6.11.3 Spago Nanomedical Gadolinium-based Contrast Media Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Spago Nanomedical Product Portfolio
        6.11.5 Spago Nanomedical Recent Developments/Updates

7 Gadolinium-based Contrast Media Manufacturing Cost Analysis
    7.1 Gadolinium-based Contrast Media Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Gadolinium-based Contrast Media
    7.4 Gadolinium-based Contrast Media Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Gadolinium-based Contrast Media Distributors List
    8.3 Gadolinium-based Contrast Media Customers

9 Gadolinium-based Contrast Media Market Dynamics
    9.1 Gadolinium-based Contrast Media Industry Trends
    9.2 Gadolinium-based Contrast Media Growth Drivers
    9.3 Gadolinium-based Contrast Media Market Challenges
    9.4 Gadolinium-based Contrast Media Market Restraints

10 Global Market Forecast
    10.1 Gadolinium-based Contrast Media Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Gadolinium-based Contrast Media by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Gadolinium-based Contrast Media by Type (2022-2027)
    10.2 Gadolinium-based Contrast Media Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Gadolinium-based Contrast Media by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Gadolinium-based Contrast Media by Application (2022-2027)
    10.3 Gadolinium-based Contrast Media Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Gadolinium-based Contrast Media by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Gadolinium-based Contrast Media by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com